journal article·2020-01-01Open access

A closer look at the genotoxicity of graphene based materials

Cansu Gurcan, Hadiseh Taheri, Alberto Bianco, Lucia Gemma Delogu, Acelya Yilmazer

Journal of Physics: Materials· Volume 3· Issue 1

Abstract

Abstract Graphene-based materials (GBMs) have attracted many scientists because of their optical, thermal, mechanical and electronic properties. Their good dispersibility in different type of solvents including water, the possibility to formulate them according to desired function, and the wide surface area, which can allow various chemical modifications, expanded the use of these materials in biological systems. For these reasons, GBMs have been extensively studied in vitro and in vivo in the biomedical field. However, the toxicity and genotoxicity of GBMs must be thoroughly investigated before they can be translated into clinical settings. The main mechanism of graphene toxicity is thought to be caused by reactive oxygen species produced in cells, which in turn interact with various biomolecules including DNA. In this review we aimed to discuss different genotoxicity studies performed with GBMs with specific focus on the different cell types and conditions. By comparing and discussing such reports, scientists will be able to engineer non toxic GBMs for future preclinical and/or clinical studies. In order to allow a safer and faster transition to clinic, future studies should involve state-of-the-art technologies such as systems biology approaches or three-dimensional microfluidic systems, which can better predict the normal physiological scenario.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Graphene: materials in the Flatland (Nobel lecture)10.1002/anie.201101502 ↗
2. Nobel lecture: random walk to graphene10.1103/RevModPhys.83.851 ↗
3. Graphene-based nanomaterials for nanobiotechnology and biomedical applications10.2217/nnm.13.140 ↗
4. Graphene for multi-functional synthetic biology: the last ‘zeitgeist’ in nanomedicine10.1016/j.bmcl.2014.01.051 ↗
5. Functional graphene nanomaterials based architectures: biointeractions, fabrications, and emerging biological applications10.1021/acs.chemrev.6b00520 ↗
6. Biomedical applications of graphene and graphene oxide10.1021/ar300159f ↗
7. Engineered carbon-nanomaterial-based electrochemical sensors for biomolecules10.1021/acsnano.5b05690 ↗
8. Prospects and challenges of graphene in biomedical applications10.1002/adma.201203700 ↗
9. Graphene platform for hairpin-DNA-based impedimetric genosensing10.1021/nn200091p ↗
10. Detection of DNA hybridization on chemically modified graphene platforms10.1039/C1AN15910K ↗
11. Promises, facts and challenges for graphene in biomedical applications10.1039/C7CS00363C ↗
12. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide10.1021/nn202190c ↗
13. Safety assessment of graphene-based materials: focus on human health and the environment10.1021/acsnano.8b04758 ↗
14. Flake size-dependent cyto and genotoxic evaluation of graphene oxide on in vitro A549, CaCo2 and vero cell lines
16. The in vitro and in vivo toxicity of graphene quantum dots10.1016/j.biomaterials.2014.03.021 ↗
17. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways10.1016/j.biomaterials.2011.09.091 ↗
18. Toxicology of graphene-based nanomaterials10.1016/j.addr.2016.04.028 ↗
19. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung10.1021/nl202515a ↗
20. Graphene: safe or toxic? The two faces of the medal10.1002/anie.201209099 ↗
21. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines10.1016/j.mrgentox.2011.09.013 ↗
22. Ocular biocompatibility evaluation of hydroxyl-functionalized graphene10.1016/j.msec.2015.01.086 ↗
23. Cyto and genotoxicities of graphene oxide and reduced graphene oxide sheets on spermatozoa10.1039/c4ra01047g ↗
24. Graphene oxide nanosheets induced genotoxicity and pulmonary injury in mice10.1016/j.etp.2017.03.002 ↗
25. Induction of chromosomal and DNA damage and histological alterations by graphene oxide nanoparticles in Swiss mice10.1080/01480545.2019.1643876 ↗
26. Toxicity of graphene and graphene oxide nanowalls against bacteria10.1021/nn101390x ↗
27. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells10.1016/j.carbon.2012.11.058 ↗
28. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells10.1016/j.biomaterials.2012.07.040 ↗
29. Synthesis and cyto-genotoxicity evaluation of graphene on mice spermatogonial stem cells10.1016/j.colsurfb.2016.07.019 ↗
30. The effects of graphene nanostructures on mesenchymal stem cells10.1016/j.biomaterials.2014.02.054 ↗
31. Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy10.1039/c2jm34330d ↗
32. Nanoparticles containing allotropes of carbon have genotoxic effects on glioblastoma multiforme cells
33. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells
34. Characterization, cytotoxicity and genotoxicity of graphene oxide and folate coupled chitosan nanocomposites loading polyprenol and fullerene based nanoemulsion against MHCC97H cells10.1166/jbn.2019.2698 ↗
35. Differential genotoxic and epigenotoxic effects of graphene family nanomaterials (GFNs) in human bronchial epithelial cells10.1016/j.mrgentox.2016.01.006 ↗
36. Can graphene quantum dots cause DNA damage in cells?10.1039/C5NR01734C ↗
37. Graphene oxide is degraded by neutrophils and the degradation products are non-genotoxic10.1039/C7NR03552G ↗
38. No cytotoxicity or genotoxicity of graphene and graphene oxide in murine lung epithelial FE1 cells in vitro10.1002/em.22017 ↗
39. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells10.1002/jat.2877 ↗
40. Translating graphene and 2D materials into medicine10.1038/natrevmats.2016.84 ↗
41. Impact of carbon nanotubes and graphene on immune cells10.1186/1479-5876-12-138 ↗
42. Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells10.1038/s41467-017-01015-3 ↗
43. Emerging systems biology approaches in nanotoxicology: towards a mechanism-based understanding of nanomaterial hazard and risk10.1016/j.taap.2015.12.014 ↗
44. Metabolomic insights of macrophage responses to graphene nanoplatelets: role of scavenger receptor CD3610.1371/journal.pone.0207042 ↗
45. Three-dimensional models for studying development and disease: moving on from organisms to organs-on-a-chip and organoids10.1039/C6IB00039H ↗
46. Nanoparticles penetrate into the multicellular spheroid-on-chip: effect of surface charge, protein corona, and exterior flow10.1021/acs.molpharmaceut.7b00726 ↗
47. Microfluidic examination of the ‘Hard’ biomolecular corona formed on engineered particles in different biological milieu10.1021/acs.biomac.8b00196 ↗
48. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors10.1089/adt.2014.573 ↗
49. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning10.3389/fphar.2018.00006 ↗
50. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles10.1080/21691401.2018.1479709 ↗
51. In vitro approaches to assess the hazard of nanomaterials10.1016/j.impact.2017.08.002 ↗